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RISK FACTORS FOR SEPTIC ARTHRITIS IN 
PATIENTS WITH JOINT DISEASE 
A Prospective Study 
CAROLA J. E. KAANDORP, DIRKJAN VAN SCHAARDENBURG, PIETA KRIJNEN, 
J. DIK F. HABBEMA, and MART A. F. J. VAN DE LAAR 
Objective. To quantify potential risk factors for 
septic arthritis, in order to identify a basis for prevention. 
Methods. The occurrence of potential risk factors 
for septic arthritis in patients with joint diseases attend- 
ing a rheumatic disease clinic was prospectively moni- 
tored at 3-month intervals over a period of 3 years. 
Potential risk factors investigated were type of joint 
disease, comorbidity, medication, joint prosthesis, in- 
fections, and invasive procedures. The frequencies of 
risk factors in patients with and those without septic 
arthritis were compared using multiple logistic regres- 
sion analysis. 
Results. There were 37 patients with and 4,870 
without septic arthritis. Risk factors for developing 
septic arthritis were age 280 years (odds ratio [OR] = 
3.5, 95% confidence interval [95% CI] 1.4-8.6), diabe- 
tes mellitus (OR = 3.3, 95% CI 1.1-10.1), rheumatoid 
arthritis (OR = 4.0, 95% CI 1.9-8.3), hip and/or knee 
prosthesis (OR = 15, 95% CI 4.1-54.3), joint surgery 
(OR = 5.1,95% CI 2.2-11.9), and skin infection (OR = 
27.2, 95% CI 7.6-97.1). 
Conclusion. These findings indicate that preven- 
tive measures against septic arthritis in patients with 
joint diseases should mainly be directed at those with 
joint prostheses and/or skin infection. 
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Septic arthritis is a serious medical problem. 
The case-fatality rate of septic arthritis is estimated to 
be 1&25%, and 25-50% of the surviving patients suffer 
a permanent loss of joint function as a result of the 
infection (1-3). 
Risk factors for acquiring septic arthritis are 
patient-related or situation-related. Patient-related fac- 
tors include diseases and medications that reduce 
immunocompetence, joint diseases, and the presence 
of joint prostheses (43). Situation-related factors are 
any events by which bacteria can reach a joint, e.g., 
joint surgery or arthrocentesis and infections or inva- 
sive procedures in other parts of the body (43). The 
reported incidence of septic arthritis varies from 2-5/ 
100,00O/year in the general population (6-8) to 28-381 
100,00O/year in patients with rheumatoid arthritis (RA) 
(7,9,10) to 40-68/100,000/year in patients with joint 
prostheses (1 1,12). Along with the aging of the popu- 
lation and the increasing availability of joint replace- 
ment procedures, the number of persons with prosthe- 
ses is growing. 
The high rates of morbidity and mortality in 
septic arthritis necessitate comprehensive assessment 
and quantification of multiple risk factors as a first step 
in the development of a strategy for the prevention of 
this condition. We have prospectively studied the 
incidence of septic arthritis in relation to risk factors in 
patients with preexisting joint diseases attending a 
large network of rheumatic disease clinics. 
PATIENTS AND METHODS 
Patient enrollment. This study was part of a prospec- 
tive study on the incidence, risk factors, and outcome of 
septic arthritis in Amsterdam, The Netherlands, between 
1990 and 1993. The Jan van Breemen Institute is a network 
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of outpatient rheumatology clinics serving a population of 
1.1 million in the Amsterdam region. In October 1990, all 
patients aged 18 years and older seen in that year and 
diagnosed as having RA, undifferentiated oligoarthritis or 
polyarthritis (UA), juvenile chronic arthritis (JCA), ankylos- 
ing spondylitis (AS), psoriatic arthritis (PsA), systemic lupus 
erythematosus (SLE), or osteoarthritis (OA) were selected 
from the central diagnosis registry. A total of 7,216 patients 
were thus selected. In a random sample of 1% per disease 
category in the RA, UA, JCA, AS, and PsA groups, the 
information in the medical record was compared with pub- 
lished criteria for these diseases (13-16). There was com- 
plete concordance between the registered diagnoses and the 
classification according to the applied criteria. A review of 
the medical records of 30 of the 88 patients with SLE (34%) 
revealed that all fulfilled the American College of Rheuma- 
tology criteria for SLE (17) and 29 had arthritis. In 100 of the 
1,365 patients with a registered diagnosis of OA of the hip or 
knee (7%), the radiographs were reviewed. In 96% of these, 
there were abnormalities of grade I1 or higher according to 
the KellgredLawrence scoring system (18). 
Protocol. After approval by the medical ethics com- 
mittee and attending physicians, letters of introduction were 
sent to the patients. Subsequently, questionnaires were 
mailed every 3 months to patients who had given informed 
consent. Four times per year the above-mentioned proce- 
dure was repeated for newly registered patients. Between 
October 1990 and October 1992 a maximum of 8 question- 
naires per patient were sent. When a patient did not return 
the questionnaire twice in succession, his or her willingness 
to continue participating was ascertained by telephone. In 
the case of a negative answer or if the questionnaire was not 
returned a third time, the patient was not contacted again. 
The questionnaire concerned the preceding 3-month period 
and contained questions about comorbidity, joint prosthesis, 
joint trauma, infections, medical and dental procedures, 
medication, and the use of antibiotic prophylaxis at the time 
of procedures (Appendix 1). 
Treatment with prednisone, azathioprine, metho- 
trexate, or cyclophosphamide was recorded as immunosup- 
pressive medication. Antibiotic prophylaxis during implan- 
tation of prosthetic joints is a standard procedure in all 
Amsterdam hospitals. Flucloxacilline or a cephalosporin is 
given intravenously one-half hour before surgery and in most 
hospitals again 6, 12, and 18 hours later. If a prosthetic joint 
is operated on, the first dose is postponed until the joint 
cavity is cultured. 
The occurrence of septic arthritis between October 
1990 and October 1993 was recorded in all patients with the 
above-mentioned joint diseases who attended the clinic 
network. Thus, case-finding was continued 1 year longer 
than the period in which questionnaires were mailed (Octo- 
ber 1990 to  October 1992). Septic arthritis was determined 
according to the modified criteria of Newman (19): a positive 
culture of joint aspirate, direct identification of microorgan- 
isms in synovial fluid or tissue, or a strong clinical suspicion 
without another explanation. Cultures with Staphylococcus 
epidermidis or Propionibacterium acnes were considered to 
be evidence of septic arthritis if there was a positive Gram 
stain or a second culture with the same result. 
Patients with septic arthritis were identified to the 
study center in several ways: 1) all participating patients 
were instructed to present a preprinted request to inform the 
study center in case of hospital admission; 2) the rheumatol- 
ogists, orthopedic surgeons, internists, pediatricians, and 
bacteriologists in the health district of Amsterdam were 
informed before the start of the study and had agreed to 
report every patient with septic arthritis or a positive joint 
culture; 3) the diagnosis registries of the 12 hospitals in the 
district reported patients with a diagnosis of septic arthritis. 
In The Netherlands, all hospitals use the same system for 
reporting of the diagnosis at discharge (20). 
All patients with septic arthritis were visited by one 
investigator. The same data as in the questionnaire were 
gathered from the history and the medical record, for the 3 
months preceding the diagnosis. To check for information 
bias, the directly obtained history and the data in the medical 
records of patients with septic arthritis who participated in 
the questionnaire were compared with the questionnaire 
answers given by the patient over the same time period. The 
2 sources of information were consistent with one another in 
all cases. Bacterial culture results were also recorded. 
Data analysis. To identify risk factors for septic 
arthritis, data on septic arthritis patients were compared 
with data on patients who did not develop arthritis. All 
patients with septic arthritis who attended the clinic network 
for the above-mentioned joint diseases were identified as 
cases. Patients with septic arthritis who did not participate in 
the questionnaire study and patients who contracted septic 
arthritis in the year after the intake period of the question- 
naire study were also included. This was done to include as 
many cases as possible from the relevant clinic population. 
All patients from the questionnaire group who did not 
acquire septic arthritis during the study period were identi- 
fied as controls. One questionnaire per control subject was 
randomly selected for study; thus, information on the con- 
trol patients from random 3-month periods was compared 
with information concerning the 3-month periods preceding 
the development of septic arthritis in the cases. 
The following potential risk factors for septic arthri- 
tis were analyzed: age, sex, presence of malignancy, diabe- 
tes mellitus, renal disease, or liver disease, type of joint 
disease, use of immunosuppressive medication, presence of 
a hip and/or knee prosthesis, skin infection, upper or lower 
respiratory tract or urinary tract infection, invasive proce- 
dures at any site including dental procedures, and joint 
trauma. Age was dichotomized (<80 versus 280) to allow a 
straightforward interpretation. The frequencies of these fac- 
tors in the 3-month periods were compared between cases 
and controls in univariate analyses (chi-square test for each 
factor). Variables were eligible for entry into a multivariate 
analysis if they were significantly associated with septic 
arthritis (P < 0.10). A multivariate logistic regression analy- 
sis was done with backward deletion of variables, based on 
the likelihood ratio test (removal P value < 0.10) in order to 
identify a set of statistically strong predictors for septic 
arthritis. Interaction between variables remaining in the 
model was investigated. Statistically significant (P < 0.05) 
interaction terms were included in the model in order to 
obtain a model that better described the data. Odds ratios 
(OR) and 95% confidence intervals were calculated for 
variables in the model. Because the OR approximates the 
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Table 1. Distribution of diagnoses among patients with joint diseases, and rate of response to the 
questionnaires 
Patients 
Questionnaires 
No. selected Initial 
from diagnosis participation Total Response 
Diagnosis registry rate (70) mailed rate (%) 
Rheumatoid arthritis 
Undifferentiated polyarthritis 
Juvenile chronic arthritis 
Ankylosing spondylitis 
Psoriatic arthritis 
Systemic lupus erythematosus 
Osteoarthritis of hip or knee 
Osteoarthritis of other sites 
Total 
1,795 
1,161 
79 
563 
257 
88 
1,365 
1,908 
7,216 
90 
90 
92 
92 
91 
92 
84 
82 
87 
9,906 
6,076 
395 
2,905 
1,374 
438 
5,744 
7,893 
34,731 
83 
80 
80 
79 
82 
80 
76 
69 
78 
relative risk in cases of small probability, ORs in this study 
are interpreted as relative risks. 
Data from the Amsterdam health district. Parallel to 
this study, the occurrence of septic arthritis in the entire 
Amsterdam region was recorded. Since information on the 
distribution of age (21) and the prevalence of RA (22) and 
diabetes mellitus (23) was available for the population of this 
region, we had the opportunity to compare the prevalence of 
these risk factors in the questionnaire group and in the 
general population. Finally, septic arthritis occurring after 
separate surgical procedures in joints was related to the total 
number of such procedures in the Amsterdam region as 
registered in the time period of the study (24). 
RESULTS 
Characteristics of the study population. The total 
number of patients selected from the diagnosis registry 
was 7,216. For 300 patients, the attending physicians 
objected to participation, and another 63 1 patients 
chose not to participate. Thus, the initial participation 
rate was 87% (Table 1). During the study period, 197 
patients died (3%). Another 584 patients (8%) dropped 
out because of relocation or difficulties with the Dutch 
language. In the course of the study period, 1,675 
patients (23%) objected to further participation. A 
total of 34,731 questionnaires was mailed to 6,285 
patients, of which 27,028 (78%) were returned by 4,889 
patients (78%). The response rate of patients with OA 
was slightly lower than that of the other patients. 
For most of the potential risk factors, except for 
age, sex, immunosuppressive medication, and the 
presence of a hip andlor knee prosthesis, the preva- 
lence was similar in the different joint disease catego- 
ries. The AS group consisted predominantly of young 
men. Immunosuppressive medication was used fre- 
quently by patients with RA (30%) and SLE (38%) and 
uncommonly in the other disease categories (2-15%). 
A hip or knee prosthesis was present in one-fourth of 
the patients with RA or OA of the hip or knee, 
compared with 2-9% of the other patients. The most 
frequent invasive procedure was a dental procedure, 
in 10% of the patients per 3 months. Fourteen percent 
of the patients with prosthetic hip and/or knee joints 
who underwent invasive procedures at sites other than 
the joints reported the use of antibiotic prophylaxis; a 
variety of regimens was used. 
Characteristics of patients with septic arthritis. 
Septic arthritis was diagnosed in 37 patients attending 
the rheumatic disease clinics: 24 during the 2 years of 
questionnaire mailing and 13 in the third year of 
case-finding. Nineteen of the 37 patients had partici- 
pated in the questionnaire. Reporting by clinicians was 
nearly complete; 2 patients were identified by check- 
ing the diagnosis registries. The occurrence of septic 
arthritis was similar between responders and nonre- 
sponders to the questionnaire (0.40% and 0.48%, re- 
spectively), as well as in patients whose physician had 
objected to their participation and the other patients 
(0.33% and 0.42%, respectively). Bacteria were cul- 
tured from joint fluid or tissue in 32 patients; in the 
other 5 patients, pus was present in the joint. The most 
frequently cultured microorganism was Stuphylococ- 
cus uureus (in 15 patients). 
There were 14 men and 23 women with septic 
arthritis, with a mean age of 65 years. The most 
common preexisting joint disease was RA, in 25 pa- 
tients. The mean duration of RA in these patients was 
22 years. Of the 25 patients with RA, 3 also had 
diabetes mellitus and 1 had a malignancy. Immunosup- 
pressive medication was used by 12 patients (all with 
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RA). The dose ranges were as follows: prednisone 
2.5-15 mg/day, azathioprine 5 6 7 5  mg/day, and metho- 
trexate 10 mg/week. The 37 patients had a total of 46 
infected joints; 4 patients had more than 1 infected 
joint. In 27 of the 37 patients, the infected joint 
contained foreign material (prosthesis [n = 241 or 
screws, to attain arthrodesis [n = 21 or for fracture 
stabilization [n =I]). The probable cause of septic 
arthritis was direct inoculation of bacteria into the 
joint in 15 patients (10 prosthetic surgery, 2 surgery 
with osteosynthesis material, 2 intraarticular injection, 
and 1 penetrating trauma). In the remaining 22 patients 
with probable hematogenous septic arthritis, a source 
of infection was identified in 13 (59%), mainly a skin 
infection. A positive skin culture was recorded in 6 
patients, the bacteria being the same as that cultured 
from the joint in all cases. 
Risk factor analysis. The results of the univari- 
ate analysis of potential risk factors are presented in 
Table 2. Frequencies between cases and controls 
differed (P < 0.05) for all patient characteristics except 
sex, renal disease, and liver disease. Age 280 years, 
malignancy, diabetes mellitus, diagnosis of RA, use of 
immunosuppressive medication, and hip andlor knee 
prosthesis were significantly associated with septic 
arthritis. Skin infections, joint surgery, and earlnosel 
throat surgery in the last 3 months were more frequent 
among cases. Dental treatment and joint trauma were 
reported more often by controls. 
The variables age, malignancy, diabetes melli- 
tus, type of joint disease, immunosuppressive medica- 
tion, hip and/or knee prosthesis, skin infection, and 
joint surgery were eligible for inclusion in the multi- 
variate analysis. Since RA was the only joint disease 
with a higher frequency among cases in the univariate 
analysis, diagnosis was dichotomized as RA versus all 
other joint disease diagnoses. Invasive procedures in 
the ear/nose/throat region appeared at first to be a risk 
factor for septic arthritis. However, in the 2 septic 
arthritis patients who had undergone earhosehhroat 
surgery, the septic arthritis was considered to be due 
to a skin infection, because the same microorganism 
was cultured from the joint and the infected skin. 
Earhosehhroat surgery was therefore not entered into 
the multivariate analysis. During backward deletion, 
malignancy and immunosuppressive medication were 
removed from the multivariate logistic regression 
model. Interaction between the remaining predictors 
was investigated. An interaction term between the 
presence of a hip and/or knee prosthesis and skin 
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Table 2. Results of univariate analysis of potential risk factors for 
septic arthritis* 
Cases Controls 
(n = 37) (n = 4,870) P Factor 
Age 280 years 
Male sex 
Malignancy 
Diabetes mellitus 
Renal disease 
Liver disease 
Joint disease 
RA 
UA 
AS 
JCA, SLE, or PsA 
OA hip or knee 
OA not hip or knee 
Immunosuppressive medication 
Hip andlor knee prosthesis 
Infection 
Skin 
Upper respiratory tract 
Lower respiratory tract 
Urinary tract 
Invasive procedure 
Joint surgery 
Intraarticular injection 
Skin 
Earlnoselthroat 
Dental 
Gastrointestinal tract 
Respiratory tract 
Urinary tract 
Female genital tract 
Joint trauma 
Prosthesis without skin infection 
No prosthesis, with skin infection 
Prosthesis and skin infection 
No prosthesis, no skin infection 3 (8) 
263 (5) <0.01 
1,487 (31) 0.34 
55 (I)  0.02 
197 (4) 0.04 
60 (1) 0.50 
30 (1) 0.11 
1,339 (27) <0.01 
855 (18) 
408 (8) 
319 (7) 
842 (17) 
1,107 (23) 
648 (13) <O.Ol 
634 (13) <O.Ol 
642 (13) <0.01 
1,433 (29) 0.16 
309 (6) 0.82 
336 (7) 0.72 
172 (4) <0.01 
212 (4) 0.75 
129 (3) 0.98 
16 (0) <0.01 
503 (10) 0.04 
136 (3) 0.30 
25 (1) 0.66 
59 (1) 0.41 
32 (1) 0.61 
518(11) 0.04 
555 (11) <0.01 
563 (12) 
79 (2) 
3,673 (7.5) 
____ ~~ 
* Values are the number (%). RA = rheumatoid arthritis; UA = 
undifferentiated arthritis; AS = ankylosing spondylitis; JCA = 
juvenile chronic arthritis; SLE = systemic lupus erythematosus; 
PsA = psoriatic arthritis; OA = osteoarthritis. 
disease was found, and this was subsequently included 
in the model. 
The results of the multivariate analysis are 
presented in Table 3. Age 80 years or older and 
presence of diabetes mellitus increased the risk for 
septic arthritis by afactor of 3.5 and 3.3, respectively. 
If age was dichotomized at values below 80, the risk 
associated with a higher age was no longer statistically 
significant. A diagnosis of RA, compared with all other 
diagnoses of joint disease, implied a 4-fold increased 
risk for septic arthritis. Joint surgery was a somewhat 
stronger risk factor (OR = 5.1). The presence of a 
prosthesis without a skin infection increased the risk 
for septic arthritis 15-fold. A skin infection in patients 
without a prosthesis increased the risk 27-fold. After 
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Table 3. 
potential risk factors for septic arthritis 
Results of multivariate logistic regression analysis of 
Risk factor 
Age 280 years 
Diabetes mellitus 
Rheumatoid arthritis 
Recent joint surgery 
Hip or knee prosthesis without skin infection 
No hip or knee prosthesis, with skin infection 
Hio or knee Drosthesis and skin infection 
Odds 
ratio 
3.5 
3.3 
4.0 
5.1 
15.0 
27.2 
72.7 
95% 
confidence 
interval 
1.4-8.6 
1.1-10.1 
1.9-8.3 
2.2-11.9 
4.1-54.3 
7.6-97.1 
18.6-282.6 
correction for interaction, the presence of both a 
prosthesis and a skin infection resulted in an OR of 73, 
compared with patients who did not have either char- 
acteristic. 
Comparison with data from the Amsterdam 
health district. During the 3 years of case-finding, 188 
episodes of septic arthritis were recorded in 186 pa- 
tients in the Amsterdam health district with or without 
preexisting joint disease. The prevalence of risk fac- 
tors in persons with and those without septic arthritis 
is presented in Table 4. As of January 1, 1992, 3% of 
the population of the Amsterdam health district was 
aged 80 years or older, whereas this figure was 12% 
(OR = 4) in the total group of patients with septic 
arthritis in this area. Diabetes mellitus was present in 
9% of the health district population between 50 and 75 
years old and in 23% of the patients with septic 
arthritis in the same age range (OR = 2.5). RA was 
found in 1% of the adult population, whereas among 
the group of patients with septic arthritis, 20% had RA 
(OR = 20). These figures are similar to the results in 
the questionnaire group, except for a higher risk 
associated with RA in the general population. 
Invasive procedures in joints were classified 
into 3 separate categories. Category 1 ,  Without pros- 
thesis: Of 12,845 procedures in 3 years, 6 (0.05%) were 
followed by septic arthritis. Four of these were an 
Table 4. Prevalence of risk factors for septic arthritis among 
persons in the Amsterdam health district with septic arthritis (cases) 
and those without septic arthritis (controls)* 
Cases Controls 
(n = lo6) (n = 188) 
~ 
Age 280 years 12 
Diabetes mellitust 23 
Rheumatoid arthritis 20 
3 
9 
1 
* Values are percentages. 
t In the age group 50-75 years old. 
arthrodesis of the ankle or foot (4 of 468; 0.9%). 
Category 2, Implantation, reimplantation, or removal 
of a joint prosthesis: These procedures were per- 
formed 4,683 times, and this was followed by septic 
arthritis 14 times (0.3%). The procedure most fre- 
quently followed by an infection was the reimplanta- 
tion of a hip prosthesis (3 of 257; 1.2%). Category 3, 
Procedures in which the use of foreign material was 
not recorded: Of 4,636 procedures, 21 (0.5%) were 
followed by septic arthritis. Five of these infections 
proved to be in prosthetic joints. In a subgroup called 
“other repair of joint structures” (105 procedures), 3 
infected elbow prostheses were found. Therefore, the 
prevalence of septic arthritis after implantation of an 
elbow prosthesis was at least 3%. 
DISCUSSION 
In this large-scale prospective study of patients 
with joint diseases, it was found that independent risk 
factors for acquiring septic arthritis are age 80 years or 
older, diabetes mellitus, RA, a hip and/or knee pros- 
thesis, recent joint surgery, and skin infection. 
At older ages, various medical conditions that 
may increase the risk of joint infection occur, e.g., 
preexisting arthritis or joint prostheses and chronic 
extraarticular disease leading to immunosuppression 
or to hematogenous spread of infection into a joint (1) .  
In the present analysis, the age factor is independent 
of the presence of RA or of a joint prosthesis; there- 
fore, the increased risk of septic arthritis in the elderly 
is probably caused by the higher prevalence of chronic 
disease (25) and a decrease in immunocompetence in 
this population as compared with younger persons 
(26). Diabetes mellitus in itself heightens susceptibility 
to infections, due to the influence of hyperglycemia on 
polymorphonuclear cell functions. The mechanisms 
involved include decreased mobilization of leukocytes 
to the site of infection (27), a defect in chemotaxis (28), 
impaired intracellular glycolysis of leukocytes leading 
to a deficient supply of the energy needed for the 
uptake of microorganisms (29), and impaired intracel- 
lular killing of microorganisms (30). In addition to 
these factors, diabetic neuropathy can lead to septic 
arthritis by way of skin infection, as occurred in 1 
patient in this study. 
RA was by far the most common joint disease 
among patients with septic arthritis. The chronic syno- 
vitis and the abnormal joint structure that are charac- 
teristic of RA provide good conditions for bacterial 
survival and growth (5). Regular intraarticular injec- 
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tions also increase the risk of infection in patients with 
RA (31), although our data confirm that the absolute 
risk is low. In the present analysis, immunosuppres- 
sive medication had no independent association with 
the occurrence of septic arthritis. 
Septic arthritis occurred infrequently in pa- 
tients with joint diseases other than RA. Of 12 such 
patients, 9 had an infected prosthesis or infected 
osteosynthetic material, and 2 developed septic arthri- 
tis after direct inoculation of bacteria into the joint. It 
appears that these factors are more important than the 
type of joint disease per se. The difference in suscep- 
tibility to septic arthritis in patients with RA as com- 
pared with other joint diseases may be related to a 
greater area with involvement of synovitis and a higher 
degree of joint destruction in RA: most of these 
patients had longstanding and destructive disease, as 
has been noted before in series of RA patients with 
septic arthritis (32). 
Prosthesis infections can originate during im- 
plantation of the prosthesis or by hematogenous 
spread from a distant source. The pathogenesis of 
these infections is related to preferential colonization 
of foreign material (33). In this analysis, cases and 
controls were compared over 3-month periods. Since 
the interval between surgery and the diagnosis of 
septic arthritis was longer than 3 months in 4 of the 12 
patients whose joints were presumably infected during 
surgery, the risk of joint surgery is underestimated. 
Data on septic arthritis in relation to the frequency of 
separate surgical procedures revealed that implanta- 
tions of elbow prostheses and revisions of hip prosthe- 
ses are associated with the highest rate of subsequent 
septic arthritis. The standard use of antibiotic prophy- 
laxis with implantation of prostheses is apparently not 
entirely effective in preventing septic arthritis. 
Skin infection is an important risk factor for 
septic arthritis. This association was confirmed by the 
congruent culture results at both sites, in cases in 
which culture results were available. All septic arthri- 
tis patients with skin infection had a clinically obvious 
infection at the site of the involved skin. Since the skin 
infection item in the questionnaire also included ec- 
zema, the OR as calculated for skin infection probably 
underestimates the effect of skin infections. All pa- 
tients with a skin infection as the cause of septic 
arthritis had RA; in half of these patients, the infection 
was located on the foot. The integrity of the skin of RA 
patients is threatened by deformations, nodules, and 
atrophy due to medication (34). 
The typical patient at risk for development of 
septic arthritis in this study was an RA patient with 1 
or more joint prostheses and skin infection. Since the 
first 2 risk factors cannot be influenced, a reduction of 
the risk for septic arthritis in this patient population 
can be achieved only by intensive treatment and 
prophylaxis of skin infections. 
In conclusion, the prevention of septic arthritis 
in patients with joint diseases should focus on patients 
who are age 80 years or older and have diabetes 
mellitus, RA, joint prostheses, joint surgery, and/or 
skin infections. To investigate the balance between the 
cost and the effect of preventive measures, informa- 
tion is needed on all aspects of the outcome of septic 
arthritis. Such an analysis is currently under way in 
this group of patients. 
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APPENDIX 1: QUESTIONNAIRE ON POTENTIAL RISK 
FACTORS FOR SEPTIC ARTHRITIS 
1. Do you have any disease, other than your joint disorder, at this 
2. Do you have one or more joint prostheses? 
3. Did you visit a doctor or dentist because of inflammation or an 
4. Have you undergone a medical procedure in the past 3 months, 
5.  Did you receive antibiotics (e.g., penicillin) in relation to the 
6. Did an inflammation occur after the procedure(s) mentioned in 
7. Did you have any complaints about your health, other than your 
8. Did you injure a joint severely in the past 3 months, for example, 
9. Did you use any medication during the past 3 months? 
the patient is asked to mark what fits his or her situation. 
moment? 
infection in the past 3 months? 
for example, joint surgery? 
procedure(s) mentioned in question 4? 
question 4, for example, wound infection? 
joint disease, in the past 3 months? 
by falling? 
A positive answer is followed by a list of possibilities from which 
In question 7 the following items could be marked: 
Fever 
Cough, cold, angina, sinusitis, otitis 
Pneumonia, bronchitis 
Pain on urinating, cystitis, kidney stone, nephritis 
Venereal disease 
Diarrhea 
Eczema, infected wound, bum, boil, abscess, decubitus ulcer, 
wound after injury, ingrown nail 
